OPIOIDS - CLINICAL USE AS ANESTHETIC AGENTS

被引:4
作者
HUG, CC
机构
[1] Department of Anesthesiology, Emory University School of Medicine, Atlanta, GA
关键词
OPIOIDS; NARCOTIC ANALGESICS; MORPHINE; FENTANYL; SUFENTANIL; ALFENTANIL; OPIOID ANESTHESIA; NARCOTIC ANESTHESIA;
D O I
10.1016/0885-3924(92)90088-Y
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Opioids (narcotic analgesics) are widely used in the practice of anesthesia for preanesthetic medication, systemic and spinal analgesia, supplementation of general anesthetic agents, and as primary anesthetics. The last use is particularly widespread for major operations, especially those involving patients with cardiovascular disease. The use of opioids in anesthetic doses is based on the absence of cardiac depression by the opioids. As with all anesthetic drugs, the opioids have limitations and side effects, but for the most part, these are easily managed on the basis of knowledge of their pharmacology. The key to their efficient use is careful titration of dose according to the individual patient's responses to the drug as well as to noxious stimulation. Although there is a very wide margin of safety, allowing administration of enormous doses intraoperatively when the patient's ventilation is supported mechanically, the disadvantage of using doses far in excess of the individual patient's need is a prolonged recovery from anesthesia with the risk of postoperative ventilatory depression. Titration of the dose can be facilitated by computer-controlled infusion pumps with the benefit that the recovery time from anesthetic doses can be appropriate for the individual patient and surgical procedure, and postoperative analgesia can be continued by patient-controlled analgesia, which is another example of computer-controlled opioid infusion. Although specific opioid antagonists are available, their use to antagonize residual anesthetic effects is potentially hazardous.
引用
收藏
页码:350 / 355
页数:6
相关论文
共 26 条
[1]  
Foldes, Swerdlow, Siker, Narcotics and narcotic antagonists, (1964)
[2]  
Lowenstein, Hallowell, Levine, Daggett, Austen, Laver, Cardiovascular responses to large doses of intravenous morphine in man, N Engl J Med, 281, pp. 1389-1393, (1969)
[3]  
Lowenstein, Morphine “anesthesia”: a perspective, Anesthesiology, 35, pp. 563-565, (1971)
[4]  
Stanley, Webster, Anesthetic requirements and cardiovascular effects of fentanyl-oxygen and fentanyl-diazepam-oxygen anesthesia in man, Anesth Analg, 57, pp. 411-416, (1978)
[5]  
Hug, Pharmacology of opioids and antagonists, General anesthesia, pp. 135-150, (1989)
[6]  
Jaffe, Martin, Opioid analgesics and antagonists, The pharmacological basis of therapeutics, pp. 485-521, (1990)
[7]  
Ausems, Hug, de Lange, Variable rate infusion of alfentanil as a supplement to nitrous oxide anesthesia for general surgery, Anesth Analg, 62, pp. 982-986, (1983)
[8]  
Hug, Does opioid “anesthesia” exist?, Anesthesiology, 73, pp. 1-4, (1990)
[9]  
Jaffe, Drug addiction and abuse, The pharmacological basis of therapeutics, pp. 522-573, (1990)
[10]  
O'Keefe, Domalik-Wawrzynski, Guerrero, Rosow, Lowenstein, Powell, Local and neurally mediated effects of sufentanil on canine skeletal muscle vascular resistance, J Pharmacol Exp Ther, 242, pp. 699-706, (1987)